![](https://d3ilqtpdwi981i.cloudfront.net/ueSNlsBUIKYzdAUAwyCk4S4kxxY=/425x550/smart/https://bepress-attached-resources.s3.amazonaws.com/uploads/99/56/00/995600dd-757e-42b7-be2d-57c0c8b79ae1/file.png)
Article
Phase II study of dasatinib in the treatment of head and neck squamous cell carcinoma (HNSCC)
Journal of Clinical Oncology
(2009)
Disciplines
Publication Date
May 20, 2009
DOI
10.1200/JCO.2009.27.15_SUPPL.6022
Citation Information
H. D. Brooks, B. Glisson, C. Lu, A. Sabichi, et al.. "Phase II study of dasatinib in the treatment of head and neck squamous cell carcinoma (HNSCC)" Journal of Clinical Oncology Vol. 27 (2009) p. 6022 - 6022 Available at: http://works.bepress.com/heather-brooks2/8/